DPP3 and neoplasm: DPP III is epigenetically induced in liver cancer cells by promoter hypomethylation, while DPP III and thimet oligopeptidase-1 (TOP-1) decrease the immunogenicity of necrotic tumor cells by blocking antigen cross-presentation [5,6].